Bella Intimates

Women's Health

"When a woman is comfortable within, she exudes confidence. And a confident woman can do anything!"

Shelly Manougian

The Best Source For Women's Health Articles

What Signs of Breast Cancer are there other than a Lump
by Essentially Women 18 May, 2023
A breast lump or mass is just one of the possible signs of breast cancer in women or men. Breast cancer can cause serveral additional changes to the skin on and around the breast. Anyone who notices any of these changes should see a doctor.
What to Know About Menopause and Sore Breasts
by Essentially Women 18 May, 2023
A person reaches menopause after 12 months without having a period. This stage follows a transitional period called perimenopause, where estrogen and progesterone levels in the body fluctuate unpredictably.
New Potential Treatment Option for Triple Negative Breast Cancer
by Essentially Women 18 May, 2023
In a recent study published in the Journal of Clinical Investigation, Mayo Clinic researchers identified that an FDA drug approved for myelodysplastic syndrome may be useful to treat triple-negative breast cancer, which is one of the most aggressive and lethal types of breast cancer.
How Does Excess Weight Drive Breast Cancer
by Essentially Women 18 May, 2023
Obesity is a known risk factor for breast cancer, but precisely how does excess weight drive the disease? A new study has shed some light, revealing the process by which obesity increases the aggression of breast cancer cells.
Breast-Feeding Reduces Breast Cancer Risk, Say New Report
by Essentially Women 18 May, 2023
A review of the latest scientific research on breast cancer shows that there is strong evidence that breast-feeding can reduce women's risk of premenopausal and postmenopausal breast cancers.
Researchers Identify Biomarker for likely Aggressive, Early-Stage Breast Cancers
by Essentially Women 18 May, 2023
The one-size-fits-all approach to early stage breast cancer creates a paradox: Millions of dollars are spent on unnecessary surgeries and radiation to treat women with low-risk 'in situ' lesions, an estimated 85% of which would never progress to invasive cancers.
Show More Articles
Share by: